SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Advanced Proteome Therapeutics Corp – ‘D’ on 5/26/20

On:  Tuesday, 5/26/20, at 11:31am ET   ·   Effective:  5/26/20   ·   Accession #:  1040368-20-1   ·   File #:  21-367643

Previous ‘D’:  ‘D’ on 9/4/18   ·   Latest ‘D’:  This Filing

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/26/20  Advanced Proteome Therapeut… Corp D           5/26/20    1:8K

Notice of an Exempt Offering of Securities   —   Form D   —   Reg. D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: D           Notice of an Exempt Offering of Securities --       HTML      8K 
                primary_doc.xml/7.8


        

This ‘D’ Document is an XML Data File that may be rendered in various formats:

  Form D    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
XML Data rendering:  Notice of an Exempt Offering of Securities
 
                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<edgarSubmission>
<schemaVersion> X0708 </schemaVersion>
<submissionType> D </submissionType>
<testOrLive> LIVE </testOrLive>
<primaryIssuer>
<cik> 0001040368 </cik>
<entityName> Advanced Proteome Therapeutics CORP </entityName>
<issuerAddress>
<street1> 104-8337 Eastlake Drive </street1>
<city> Burnaby </city>
<stateOrCountry> A1 </stateOrCountry>
<stateOrCountryDescription> BRITISH COLUMBIA, CANADA </stateOrCountryDescription>
<zipCode> V5A 4W2 </zipCode>
</issuerAddress>
<issuerPhoneNumber> 6048978025 </issuerPhoneNumber>
<jurisdictionOfInc> BRITISH COLUMBIA, CANADA </jurisdictionOfInc>
<issuerPreviousNameList>
<previousName> Advanced Proteome Therapeutics (Canada) Inc. </previousName>
</issuerPreviousNameList>
<edgarPreviousNameList>
<previousName> THRILLTIME ENTERTAINMENT INTERNATIONAL INC </previousName>
<previousName> NEWERA CAPITAL CORP </previousName>
</edgarPreviousNameList>
<entityType> Corporation </entityType>
<yearOfInc>
<overFiveYears> true </overFiveYears>
</yearOfInc>
</primaryIssuer>
<relatedPersonsList>
<relatedPersonInfo>
<relatedPersonName>
<firstName> Paul </firstName>
<lastName> Woodward </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> 804-750 West Pender Street </street1>
<city> Vancouver </city>
<stateOrCountry> A1 </stateOrCountry>
<stateOrCountryDescription> BRITISH COLUMBIA, CANADA </stateOrCountryDescription>
<zipCode> V6C 2T7 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Executive Officer </relationship>
<relationship> Director </relationship>
</relatedPersonRelationshipList>
<relationshipClarification> President and CEO </relationshipClarification>
</relatedPersonInfo>
<relatedPersonInfo>
<relatedPersonName>
<firstName> Martin </firstName>
<lastName> Woodward </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> 804-750 West Pender Street </street1>
<city> Vancouver </city>
<stateOrCountry> A1 </stateOrCountry>
<stateOrCountryDescription> BRITISH COLUMBIA, CANADA </stateOrCountryDescription>
<zipCode> V6C 2T7 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Executive Officer </relationship>
<relationship> Director </relationship>
</relatedPersonRelationshipList>
<relationshipClarification> Secretary </relationshipClarification>
</relatedPersonInfo>
<relatedPersonInfo>
<relatedPersonName>
<firstName> Ken </firstName>
<lastName> Phillippe </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> 804-750 West Pender Street </street1>
<city> Vancouver </city>
<stateOrCountry> A1 </stateOrCountry>
<stateOrCountryDescription> BRITISH COLUMBIA, CANADA </stateOrCountryDescription>
<zipCode> V6C 2T7 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Executive Officer </relationship>
</relatedPersonRelationshipList>
<relationshipClarification> CFO </relationshipClarification>
</relatedPersonInfo>
<relatedPersonInfo>
<relatedPersonName>
<firstName> Ben </firstName>
<lastName> Catalano </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> 804-750 West Pender Street </street1>
<city> Vancouver </city>
<stateOrCountry> A1 </stateOrCountry>
<stateOrCountryDescription> BRITISH COLUMBIA, CANADA </stateOrCountryDescription>
<zipCode> V6C 2T7 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Director </relationship>
</relatedPersonRelationshipList>
<relationshipClarification></relationshipClarification>
</relatedPersonInfo>
</relatedPersonsList>
<offeringData>
<industryGroup>
<industryGroupType> Biotechnology </industryGroupType>
</industryGroup>
<issuerSize>
<revenueRange> No Revenues </revenueRange>
</issuerSize>
<federalExemptionsExclusions>
<item> 06b </item>
</federalExemptionsExclusions>
<typeOfFiling>
<newOrAmendment>
<isAmendment> false </isAmendment>
</newOrAmendment>
<dateOfFirstSale>
<value> 2020-05-19 </value>
</dateOfFirstSale>
</typeOfFiling>
<durationOfOffering>
<moreThanOneYear> false </moreThanOneYear>
</durationOfOffering>
<typesOfSecuritiesOffered>
<isEquityType> true </isEquityType>
<isOptionToAcquireType> true </isOptionToAcquireType>
<isSecurityToBeAcquiredType> true </isSecurityToBeAcquiredType>
<isOtherType> true </isOtherType>
<descriptionOfOtherType> Each unit consists of 1 common share and 1 transferable share purchase warrant. Each warrant is exercisable at a price of CAD$0.10 per share for 2 years. </descriptionOfOtherType>
</typesOfSecuritiesOffered>
<businessCombinationTransaction>
<isBusinessCombinationTransaction> false </isBusinessCombinationTransaction>
<clarificationOfResponse></clarificationOfResponse>
</businessCombinationTransaction>
<minimumInvestmentAccepted> 0 </minimumInvestmentAccepted>
<salesCompensationList></salesCompensationList>
<offeringSalesAmounts>
<totalOfferingAmount> 342286 </totalOfferingAmount>
<totalAmountSold> 127151 </totalAmountSold>
<totalRemaining> 215135 </totalRemaining>
<clarificationOfResponse> The additional USD$215,135 may be received upon the exercise of warrants sold inside and outside the U.S. US dollar amounts are based on the Bank of Canada noon rate of exchange on May 19/20, CAD$1.3898 = US$1; and May 22/20, CAD$1.4015 = USD$1. </clarificationOfResponse>
</offeringSalesAmounts>
<investors>
<hasNonAccreditedInvestors> false </hasNonAccreditedInvestors>
<totalNumberAlreadyInvested> 3 </totalNumberAlreadyInvested>
</investors>
<salesCommissionsFindersFees>
<salesCommissions>
<dollarAmount> 0 </dollarAmount>
</salesCommissions>
<findersFees>
<dollarAmount> 0 </dollarAmount>
</findersFees>
<clarificationOfResponse></clarificationOfResponse>
</salesCommissionsFindersFees>
<useOfProceeds>
<grossProceedsUsed>
<dollarAmount> 0 </dollarAmount>
</grossProceedsUsed>
<clarificationOfResponse></clarificationOfResponse>
</useOfProceeds>
<signatureBlock>
<authorizedRepresentative> false </authorizedRepresentative>
<signature>
<issuerName> Advanced Proteome Therapeutics CORP </issuerName>
<signatureName> /s/ Paul Woodward </signatureName>
<nameOfSigner> Paul Woodward </nameOfSigner>
<signatureTitle> President and CEO </signatureTitle>
<signatureDate> 2020-05-26 </signatureDate>
</signature>
</signatureBlock>
</offeringData>
</edgarSubmission>


↑Top
Filing Submission 0001040368-20-000001   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., May 3, 5:52:17.1am ET